What Potentially Modifiable Factors are Associated With Treatment Nonadherence in Pediatric Growth Hormone Deficiency? A Quantitative Study

被引:5
作者
Graham, Selina [1 ]
Neo, Samantha [2 ]
Auyeung, Vivian [1 ]
Weinman, John [1 ]
机构
[1] Kings Coll London, Sch Canc & Pharmaceut Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England
[2] Kings Coll London, Hlth Psychol Sect, London, England
关键词
growth hormone deficiency (GHD); recombinant human growth hormone (rhGH) treatment; adherence; quantitative; ILLNESS PERCEPTIONS; ADHERENCE; THERAPY; CHILDREN; PARADIGM; BURDEN;
D O I
10.4158/EP-2020-0543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A recent systematic review reported that up to 71% of patients with growth hormone deficiency and their families are nonadherent to treatment as prescribed. Nonadherence to growth hormone treatment presents a substantial and costly problem for the patient, health care provider, and health care system. The current study uniquely investigated the potentially modifiable factors associated with treatment nonadherence in this endocrine disorder. Methods: The cross-sectional study was conducted among 82 parent/caregivers of children with growth hormone deficiency who were receiving growth hormone treatment. Self-report questionnaires investigated parent/caregiver perceptions and experiences of their child's condition and prescribed treatment, in addition to their perceived relationship with their health care professional. The 8-item Morisky medication adherence scale was used for the assessment of treatment adherence. Results: Sixty-two percent of parents/caregivers were found to be nonadherent to growth hormone treatment as prescribed. Illness perceptions (consequences, identity, and coherence) and treatment concerns were found to be significantly associated with treatment adherence, as was the quality of the health care professional-parent/caregiver relationship. Conclusion: The study confirmed the extent of the adherence problem evident among the pediatric growth hormone deficiency population. In addition, it presented an insight into the explanatory factors that underpin nonadherence to growth hormone treatment. Our findings can be used to inform the development of adherence-focused interventions, with the purpose of supporting patients and their families and improving the use of prescribed growth hormone treatment within endocrine clinical practice. (C) 2020 AACE. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 39 条
  • [1] Mothers' Experiences of Caring for Children Receiving Growth Hormone Treatment
    Alsaigh, Rasha
    Coyne, Imelda
    [J]. JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2019, 49 : E63 - E73
  • [2] Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
    不详
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (42) : 1 - +
  • [3] [Anonymous], 2019, J ENDOCR SOC, DOI DOI 10.1210/JS.2019-SUN-258
  • [4] ADHERENCE TO GROWTH HORMONE THERAPY: RESULTS OF A MULTICENTER STUDY
    Aydin, Banu Kucukemre
    Aycan, Zehra
    Siklar, Zeynep
    Berberoglu, Merih
    Ocal, Gonul
    Cetinkaya, Semra
    Bas, Veysel Nijat
    Kendirci, Havva Nur Peltek
    Cetinkaya, Ergun
    Darcan, Sukran
    Goksen, Damla
    Evliyaoglu, Olcay
    Sukur, Mine
    Bas, Firdevs
    Darendeliler, Feyza
    [J]. ENDOCRINE PRACTICE, 2014, 20 (01) : 46 - 51
  • [5] PREVALENCE AND CORRELATES OF ADHERENCE IN CHILDREN AND ADOLESCENTS TREATED WITH GROWTH HORMONE: A MULTICENTER ITALIAN STUDY
    Bagnasco, Francesca
    Di Iorgi, Natascia
    Roveda, Andrea
    Gallizia, Annalisa
    Haupt, Riccardo
    Maghnie, Mohamad
    [J]. ENDOCRINE PRACTICE, 2017, 23 (08) : 929 - 941
  • [6] Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI DOI 10.1191/1478088706QP063OA
  • [7] The Brief Illness Perception Questionnaire
    Broadbent, Elizabeth
    Petrie, Keith J.
    Main, Jodie
    Weinman, John
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2006, 60 (06) : 631 - 637
  • [8] Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency
    Brod, Meryl
    Hojbjerre, Lise
    Alolga, Suzanne Lessard
    Beck, Jane F.
    Wilkinson, Lars
    Rasmussen, Michael Hojby
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2017, 10 (05) : 653 - 666
  • [9] Understanding burden of illness for child growth hormone deficiency
    Brod, Meryl
    Alolga, Suzanne Lessard
    Beck, Jane F.
    Wilkinson, Lars
    Hojbjerre, Lise
    Rasmussen, Michael Hojby
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (07) : 1673 - 1686
  • [10] Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207